All Day Allergy Relief
- Product NDC
- 55910-039
- 11-digit product format
- 559100039
- Labeler code
- 55910
- Product ID
- 55910-039_41bbe91b-7c66-4998-89ab-263654c4fb6d
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Cetirizine HCL
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)
- Application
- ANDA077946
- Marketing category
- ANDA
- Marketing start
- 2019-07-01
- Marketing end
- 2027-01-31
- Substance
- CETIRIZINE HYDROCHLORIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- All Day Allergy Relief
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CETIRIZINE HYDROCHLORIDE | 10 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 64O047KTOA |
| Rxcui | 1014678 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 55910-039-45 | All Day Allergy Relief | 1 in 1 BOX | TABLET | 1 | | 4 |
| 55910-039-45 | All Day Allergy Relief | 45 in 1 BOTTLE, PLASTIC | TABLET | 45 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 55910-039 | ALL DAY ALLERGY RELIEF (CETIRIZINE HCL) TABLET [DOLGENCORP, INC. (DOLLAR GENERAL & REXALL)] | 3 | Current NDC, Legacy NDC, 2 package rows | 20221108_76ec3257-9206-4a0f-a2cf-8a05217b92e7.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 55910-039-45 | 55910003945 | 1 BOTTLE, PLASTIC in 1 BOX (55910-039-45) / 45 TABLET in 1 BOTTLE, PLASTIC | 2019-07-01 | 2027-01-31 | No | No | Current |